Selenium in the treatment of mild-to-moderate Graves' orbitopathy: a 5-year prospective controlled cohort study.
Wang C, Qiao J, Liu S, Piao S, Zhou Y, Hu Y, Wan C, Sun Y, Ning H, Chen L, Zhang H, Hu R, Wang H, Wang W, Zhao L, Mao J, Li M, Teng W, Shan Z, Li Y.
Wang C, et al. Among authors: zhang h.
Endocrine. 2024 Jun;84(3):1072-1080. doi: 10.1007/s12020-023-03672-5. Epub 2024 Jan 10.
Endocrine. 2024.
PMID: 38200401
Clinical Trial.